Zhang et al. found that treating galectin-3 knockdown breast cancer cells with the apoptotic inducer arsenic trioxide increased its apoptotic effects compared to galectin-3-positive breast cancer cells, demonstrating an association between galectin-3 expression and chemotherapeutic resistance [10]. This evidence concerns the gene LGALS3 and breast carcinoma.